Article info

Download PDFPDF
Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia

Authors

  1. Correspondence to Dr Teoman Soysal, Division of Hematology, Department of Internal Medicine, Istanbul University, Cerrahpasa Faculty of Medicine, Fatih, Istanbul 34303, Turkey; teomansoysal{at}gmail.com
View Full Text

Citation

Tanrikulu Simsek E, Eskazan AE, Cengiz M, et al
Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia

Publication history

  • Received August 7, 2015
  • Revised December 4, 2015
  • Accepted December 23, 2015
  • First published January 25, 2016.
Online issue publication 
August 17, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.